Outcome Of Patients With Chronic Lymphocytic Leukemia (Cll) Receiving First Line Therapy: A Swedish Nation-Wide Study On 1053 Consecutive Patients Treated Between 2007 And 2013

Background: The incidence of chronic lymphocytic leukemia (CLL) in Sweden is about 500/year. Previous US data suggest that region and type of institution/hospital where patients were treated may affect outcome. Swedish results may differ as almost all CLL patients are treated within public health care, most treatment decisions are taken at therapy conferences and we have a widespread usage of yearly updated national CLL guidelines.